Anticoagulation Therapy After Biologic Aortic Valve Replacement

Objectives: Thromboembolism prophylaxis after biologic aortic valve replacement (BAVR) is recommended for 3 months postoperatively. We examined the continuation of oral anticoagulation (OAC) treatment and its effect on the long-term prognosis after BAVR. Methods: We used nation-wide register data fr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Cardiovasc Med
Autors principals: Myllykangas, Monna E., Kiviniemi, Tuomas O., Gunn, Jarmo M., Salomaa, Veikko V., Pietilä, Arto, Niiranen, Teemu J., Aittokallio, Jenni
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Cardiovascular Medicine
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8256261/
https://ncbi.nlm.nih.gov/pubmed/34235192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2021.698784
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars